+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Biomarkers Market - Global Forecast 2026-2032- Product Image
Brain Biomarkers Market - Global Forecast 2026-2032- Product Image
New

Brain Biomarkers Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011102
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain biomarkers market is experiencing renewed momentum as scientific developments and clinical needs converge, positioning advanced biomarker solutions at the core of modern neurology and diagnostic innovation.

Market Snapshot: Brain Biomarkers Market Growth and Key Trends

The Brain Biomarkers Market grew from USD 12.50 billion in 2025 to USD 14.64 billion in 2026. It is expected to continue growing at a CAGR of 18.37%, reaching USD 40.74 billion by 2032. This trajectory underscores strong commercial potential, fueled by rising demand for early neurologic disease detection, actionable diagnostics, and integration of multi-modal evidence into clinical practice. Growth is driven by advances in molecular profiling, imaging capabilities, and data analytics, with a parallel push for operational scalability and supply chain resilience across regions.

Scope & Segmentation: Opportunities Across Stakeholders and Technologies

This report provides a detailed segmentation analysis to help senior leaders identify strategic opportunities in the brain biomarkers sector. Covered areas include:

  • Biomarker Types: Genetic markers (gene expression, microRNA, single nucleotide polymorphisms), imaging-derived, metabolite-based, and protein biomarkers, each informing distinct aspects of disease characterization and monitoring.
  • Disease Targets: Focused on Alzheimer’s disease, epilepsy, multiple sclerosis, Parkinson’s disease, and stroke, with each area showing unique development trajectories and adoption considerations.
  • Sample Matrices: Blood (plasma, serum), cerebrospinal fluid, saliva, and urine, offering a spectrum of diagnostic accessibility and invasiveness for diverse clinical workflows.
  • Technologies: Chromatography (HPLC, UHPLC), mass spectrometry (GC-MS, LC-MS), immunoassays (ELISA, lateral flow), and high-throughput molecular platforms (next-generation sequencing, PCR variants) facilitate targeted detection and scalable development.
  • End Users: Contract research organizations, diagnostic laboratories, hospitals, pharmaceutical companies, and research institutes, each adopting unique roles in development, validation, and deployment.
  • Regions: Analysis across the Americas, Europe Middle East & Africa, and Asia-Pacific, reflecting regulatory environments, investment patterns, and infrastructure capabilities shaping the brain biomarkers landscape.

Key Takeaways: Strategic Imperatives and Market Shifts

  • Technological convergence—across sequencing, imaging, and AI analytics—enables integrated diagnostic frameworks and multi-modal biomarker utility for earlier disease detection.
  • Stakeholder priorities are shifting toward reproducibility, clinical validity, and evidence of real-world utility, prompting greater collaboration between technology specialists and clinical researchers to accelerate standardization and regulatory engagement.
  • Clinical adoption is increasingly driven by demonstration of incremental value in care pathways, with payers and regulators expecting robust validation and health-economic studies to support reimbursement and integration.
  • Regional regulatory approaches and infrastructure investments set the pace and uptake pattern for new biomarker solutions, with agile manufacturing and supplier diversification emerging in response to policy shifts and cost pressures.
  • Strategic alliances facilitate access to diverse clinical cohorts and real-world workflows early in development, supporting smoother clinical integration and faster market entry for innovative brain biomarker platforms.

Tariff Impact: 2025 US Trade Measures and Supply Chain Response

Tariffs introduced in the United States in 2025 have affected sourcing and manufacturing strategies across the brain biomarker ecosystem. Organizations have responded by:

  • Reevaluating sourcing decisions for reagents, instrumentation, and consumables to mitigate increased costs.
  • Implementing supplier diversification and exploring regional manufacturing or local assembly to ensure continuity in critical workflows.
  • Negotiating more flexible procurement contracts and contingency plans, especially where cross-border partnerships involve biological materials and specialized components.
  • Elevating the importance of supply chain transparency and long-term supplier relationships to sustain research and diagnostic timelines.

Methodology & Data Sources

This report synthesizes peer-reviewed literature, regulatory guidance, technical appraisals, and expert interviews. The evidence-driven approach prioritizes reproducibility, triangulates findings across diverse sources, and evaluates platforms for compatibility with clinical workflows, ensuring that actionable insights are credible and directly relevant to decision-makers.

Why This Report Matters

  • Gain a grounded perspective on where innovation, regulatory focus, and commercial adoption intersect in the brain biomarkers market.
  • Inform supply chain design, strategic partnership decisions, and investment allocations for measurable impact on research, validation, and deployment success.

Conclusion

The transition toward integrated, validated brain biomarker solutions is reshaping diagnostic and therapeutic pathways. Leaders aligned on robust evidence generation, operational readiness, and cross-sector collaboration will unlock practical value and drive sustainable clinical adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brain Biomarkers Market, by Biomarker Type
8.1. Genetic
8.1.1. Gene Expression Markers
8.1.2. Mirna Markers
8.1.3. Snp Markers
8.2. Imaging
8.2.1. CT
8.2.2. MRI
8.2.3. PET
8.3. Metabolite
8.3.1. Lipid Metabolites
8.3.2. Small Molecule Metabolites
8.4. Protein
8.4.1. CSF Proteins
8.4.2. Plasma Proteins
8.4.3. Saliva Proteins
9. Brain Biomarkers Market, by Disease Indication
9.1. Alzheimer's Disease
9.2. Epilepsy
9.3. Multiple Sclerosis
9.4. Parkinson's Disease
9.5. Stroke
10. Brain Biomarkers Market, by Sample Type
10.1. Blood
10.1.1. Plasma
10.1.2. Serum
10.2. Cerebrospinal Fluid
10.3. Saliva
10.4. Urine
11. Brain Biomarkers Market, by Technology
11.1. Chromatography
11.2. Immunoassay
11.3. Mass Spectrometry
11.4. Next Generation Sequencing
11.5. PCR
12. Brain Biomarkers Market, by End User
12.1. Contract Research Organizations
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Pharmaceutical Companies
12.5. Research Institutes
13. Brain Biomarkers Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Brain Biomarkers Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Brain Biomarkers Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Brain Biomarkers Market
17. China Brain Biomarkers Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. ADx NeuroSciences NV
18.7. Amprion, Inc.
18.8. Banyan Biomarkers, Inc.
18.9. Biogen Inc.
18.10. C2N Diagnostics, LLC
18.11. DiaSorin S.p.A.
18.12. Eli Lilly and Company
18.13. F. Hoffmann-La Roche AG
18.14. Fujirebio Diagnostics, Inc.
18.15. Janssen Pharmaceuticals, Inc.
18.16. Merck KGaA
18.17. Mesoscale Discovery, LLC
18.18. Novartis AG
18.19. Quanterix Corporation
18.20. Quretec Ltd.
18.21. Roche Holding AG
18.22. Siemens Healthineers AG
List of Figures
FIGURE 1. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRAIN BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BRAIN BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENE EXPRESSION MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENE EXPRESSION MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENE EXPRESSION MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MIRNA MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MIRNA MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MIRNA MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SNP MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SNP MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SNP MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LIPID METABOLITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LIPID METABOLITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LIPID METABOLITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SMALL MOLECULE METABOLITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SMALL MOLECULE METABOLITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SMALL MOLECULE METABOLITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CSF PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CSF PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CSF PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CEREBROSPINAL FLUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CEREBROSPINAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CEREBROSPINAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 168. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 169. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 170. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 171. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 174. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 189. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 190. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 191. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 193. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 194. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 196. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 212. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 213. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 214. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 215. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 216. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 217. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 219. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. ASEAN BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. GCC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. GCC BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 223. GCC BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 224. GCC BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 225. GCC BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 226. GCC BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 227. GCC BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 228. GCC BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 229. GCC BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 230. GCC BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. GCC BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. BRICS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 245. BRICS BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 246. BRICS BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 247. BRICS BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 248. BRICS BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 249. BRICS BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 250. BRICS BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 252. BRICS BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. BRICS BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. G7 BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. G7 BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 256. G7 BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 257. G7 BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 258. G7 BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 259. G7 BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 260. G7 BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 261. G7 BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 262. G7 BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 263. G7 BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. G7 BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. NATO BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. NATO BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 267. NATO BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 268. NATO BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 269. NATO BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 270. NATO BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 271. NATO BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 272. NATO BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 273. NATO BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 274. NATO BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. NATO BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. CHINA BRAIN BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. CHINA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 290. CHINA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC, 2018-2032 (USD MILLION)
TABLE 291. CHINA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
TABLE 292. CHINA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE, 2018-2032 (USD MILLION)
TABLE 293. CHINA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN, 2018-2032 (USD MILLION)
TABLE 294. CHINA BRAIN BIOMARKERS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 295. CHINA BRAIN BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 296. CHINA BRAIN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 297. CHINA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 298. CHINA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Brain Biomarkers market report include:
  • Abbott Laboratories
  • ADx NeuroSciences NV
  • Amprion, Inc.
  • Banyan Biomarkers, Inc.
  • Biogen Inc.
  • C2N Diagnostics, LLC
  • DiaSorin S.p.A.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Fujirebio Diagnostics, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Merck KGaA
  • Mesoscale Discovery, LLC
  • Novartis AG
  • Quanterix Corporation
  • Quretec Ltd.
  • Roche Holding AG
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.64 Billion
Forecasted Market Value ( USD ) by 2032 $ 40.74 Billion
Compound Annual Growth Rate18.3%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Neurological Biomarkers Market - Global Forecast 2026-2032 - Product Image

Neurological Biomarkers Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report - Product Image

Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Neurological Biomarkers Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2025-2033 - Product Image

Neurological Biomarkers Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2025-2033

  • Report
  • 147 Pages
  • Global
From
Neurological Biomarkers - Global Strategic Business Report - Product Image

Neurological Biomarkers - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Brain Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Brain Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Neurological Biomarker Market

A neurological biomarker is a biological indicator of a neurological disorder or disease. It is used to diagnose, monitor, and predict the progression of neurological diseases. Neurological biomarkers can be found in a variety of biological samples, such as blood, cerebrospinal fluid, and tissue. They can also be used to measure the effectiveness of treatments. Neurological biomarkers are becoming increasingly important in the field of personalized medicine, as they can provide a more accurate diagnosis and prognosis of neurological diseases. They can also be used to identify potential drug targets and to monitor the progression of neurological diseases. The neurological biomarker market is growing rapidly, driven by the increasing prevalence of neurological diseases, the development of new technologies, and the increasing demand for personalized medicine. The market is expected to continue to grow in the coming years, as more companies enter the market and develop new technologies. Some of the major companies in the neurological biomarker market include Bio-Rad Laboratories, Inc., BioMérieux SA, Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.